Nurses, Healthy Women and Preventive Gynecological Examinations - Vlora City Scenario, Albania

  • Published : 2016.02.05


Background: Nurses play an important role in preventive medicine because they represent the largest sector of health professionals. This role is very crucial in developing countries, which are going through rapid societal and economic changes, associated with a rising burden of cancers due to different risk factors. The current study aimed to compare health awareness between nurses and healthy women regarding preventive gynecological examinations and to answer the question - can nurses make a difference in women's health? Materials and Methods: This cross sectional research included a total of 150 women, 70 nurses and 80 healthy women, randomly selected. Data were collected in 2014 in Vlora city through a self-administered questionnaire that assessed different variables about preventive gynecological examinations. Results: Cervical screening rates were 20.3% and 41.8%, respectively, for nurses and healthy women, despite the former having a statistical significant greater knowledge of risk factors and symptoms. Conclusions: Even if the health awareness of nurse participants can be considered good, they need themselves to increase participation rates in cervical screening if they are to provide role models for health education/promotion addressing misconceptions and barriers.


  1. American Cancer Society (2013).
  2. Bedford S (2009).Cervical cancer: physiology, risk factors, vaccination and treatment. Br J Nurs, 18, 80-4.
  3. Bray F, Jemal A, Grey N, et al (2012). Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol, 13, 790-801.
  4. Chacko S (2014). Effect of structured teaching programme on VIA test for early detection and diagnosis of cervical cancer. Nurs J India, 105, 221-4.
  5. Cook O, McIntyre M, Recoche K (2015). Exploration of the role of specialist nurses in the care of women with gynaecological cancer: a systematic review. J Clin Nurs, 24, 683-95.
  6. Farshbaf-K. A, Salehi-P. H, Shahnazi M, et al (2015). Effect of structured teaching programme on VIA test for early detection and diagnosis of cervical cancer, Nurs J India. 105, 221-4.
  7. Fatjona K, Gjergji Th, Yllka B, et al (2014).An overview of cervical cancer knowledge and screening among female health care practitioners. Eur Scientific J, 10, 30.
  8. Fatjona K, Gjergji Th, Vjollca N, et al (2014). Vlora womens and cervical cancer screening: a study of awareness and barriers. J MacroTrends Health and Med, 2. 120-30.
  9. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al ( 2014). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer, 49, 1374-403.
  10. Henley SJ, Singh S, King J, et al (2014). Invasive cancer incidence - United States, 2010. MMWR Morb Mortal Wkly Rep, 63, 253-9.
  11. Isil I. A, Asiye G (2015). Breast, cervix and colorectal cancer knowledge among nurses in Turkey. Asian Pac J Cancer Prev, 15, 2267-72.
  12. Justin L, Dana R. G (2012). Evidence-Based Cervical Cancer Screening: The Modern Evolution of the Pap Smear, Evidence Based Medicine - Closer to Patients or Scientists?, Prof. Nikolaos Sitaras (Ed.), ISBN: 978-953-51-0504-6, InTech, Available from:
  13. Karen L, Geri L.-W, Joyce D (2014). Predictors of cervical cancer screening adherence in the United States: A Systematic Review. J Adv Pract Oncol, 5, 31-41.
  14. Moreno V, Bosch FX, Munoz N, et al (2002): Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet, 359, 1085-92.
  15. Munoz N, Franceschi S, Bosetti C, et al (2002). Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet, 359, 1093-101.
  16. National Cancer Institute (2014). Cervical Cancer Screening; 07/09/2014 09:17 AM EDT.
  17. Nesrin R, Hatice B, Sevinc K, et al (2012). Knowledge, behavior and beliefs related to cervical cancer and screening among Turkish women. Asian Pac J Cancer Prev, 13, 1463-70 .
  18. Remschmidt C, Kaufmann AM, Hagemann I, et al (2013). Risk factors for cervical human papillomavirus infection and high-grade intraepithelial lesion in women aged 20 to 31 years in Germany. Int J Gynecol Cancer, 23, 519-26.
  19. Roura E, Castellsague X, Pawlita M, et. al (2014). Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort. Int J Cancer. 135, 453-66.
  20. Sengul D, Altinay S, Oksuz H, et al (2014). Population-based cervical screening outcomes in Turkey over a period of approximately nine and a half years with emphasis on results for women aged 30-34. Asian Pac J Cancer Prev, 15, 2069-74.
  21. Shoou-Yih D. Lee,Tzu-I T, Yi-Wen T, et al (2012). Health literacy and women's health-related behaviors in Taiwan. Health Educ Behav, 3, 75.
  22. Stark A, Gregoire L, Pilarski R, et al (2008).Human papillomavirus, cervical cancer and women's knowledge. Cancer Detect Prev, 32, 15-22.
  23. Visanuyothin S, Chompikul J, Mongkolchati A (2015). Determinants of cervical cancer screening adherence in urban areas of Nakhon Ratchasima Province, Thailand. J Infect, 8, 543-52.
  24. Yanikkerem E, Goker A, Piro N, et al (2013) Knowledge about cervical cancer, pap test and barriers towards cervical screening of women in Turkey. J Cancer Educ, 28, 375-83.

Cited by

  1. Lower Incidence of Positive Gynecological Cancers in Examinees of a Unique Health Check-Up Institute, Ningen Dock in Japan, 2011-2016 vol.07, pp.05, 2017,